Selected research
Market Analysis & Forecast
Global Injectable Packaging Market Analysis and Forecast 2026-2032
Market perspective
The global Injectable Packaging market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Injectable Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Injectable Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Injectable Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Injectable Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Injectable Packaging include Schott AG, Gerresheimer AG, West Pharmaceutical Services, Stevanato Group, Becton, Dickinson and Company, Catalent, SGD Pharma, Nipro Corporation and Datwyler Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Injectable Packaging, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Injectable Packaging, also provides the revenue of main regions and countries. Of the upcoming market potential for Injectable Packaging, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Injectable Packaging revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Injectable Packaging market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Injectable Packaging revenue, projected growth trends, production technology, application and end-user industry.
Injectable Packaging Segment by Company
Schott AG
Gerresheimer AG
West Pharmaceutical Services
Stevanato Group
Becton, Dickinson and Company
Catalent
SGD Pharma
Nipro Corporation
Datwyler Group
Stevanato Group's Ompi
SGD Pharma's Gerresheimer
Injectable Packaging Segment by Type
Vial
Injection
Cartridge
Other
Injectable Packaging Segment by Application
Hospitals and Medical Facilities
Pharmaceutical Company
Other
Injectable Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Injectable Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Injectable Packaging in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Injectable Packaging company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Injectable Packaging revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vial
- Injection
- Cartridge
- Other
Applications
- Hospitals and Medical Facilities
- Pharmaceutical Company
- Other
Companies covered
- Schott AG
- Gerresheimer AG
- West Pharmaceutical Services
- Stevanato Group
- Becton, Dickinson and Company
- Catalent
- SGD Pharma
- Nipro Corporation
- Datwyler Group
- Stevanato Group's Ompi
- SGD Pharma's Gerresheimer
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Injectable Packaging Market by Type
- 1.2.1 Global Injectable Packaging Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Vial
- 1.2.3 Injection
- 1.2.4 Cartridge
- 1.2.5 Other
- 1.3 Injectable Packaging Market by Application
- 1.3.1 Global Injectable Packaging Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospitals and Medical Facilities
- 1.3.3 Pharmaceutical Company
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Injectable Packaging Market Dynamics
- 2.1 Injectable Packaging Industry Trends
- 2.2 Injectable Packaging Industry Drivers
- 2.3 Injectable Packaging Industry Opportunities and Challenges
- 2.4 Injectable Packaging Industry Restraints
3 Global Growth Perspective
- 3.1 Global Injectable Packaging Market Perspective (2021-2032)
- 3.2 Global Injectable Packaging Growth Trends by Region
- 3.2.1 Global Injectable Packaging Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Injectable Packaging Market Size by Region (2021-2026)
- 3.2.3 Global Injectable Packaging Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Injectable Packaging Revenue by Players
- 4.1.1 Global Injectable Packaging Revenue by Players (2021-2026)
- 4.1.2 Global Injectable Packaging Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Injectable Packaging Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Injectable Packaging Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Injectable Packaging Key Players Headquarters & Area Served
- 4.4 Global Injectable Packaging Players, Product Type & Application
- 4.5 Global Injectable Packaging Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Injectable Packaging Market CR5 and HHI
- 4.6.3 2025 Injectable Packaging Tier 1, Tier 2, and Tier 3
5 Injectable Packaging Market Size by Type
- 5.1 Global Injectable Packaging Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Injectable Packaging Revenue by Type (2021-2032)
- 5.3 Global Injectable Packaging Revenue Market Share by Type (2021-2032)
6 Injectable Packaging Market Size by Application
- 6.1 Global Injectable Packaging Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Injectable Packaging Revenue by Application (2021-2032)
- 6.3 Global Injectable Packaging Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Schott AG
- 7.1.1 Schott AG Company Information
- 7.1.2 Schott AG Business Overview
- 7.1.3 Schott AG Injectable Packaging Revenue and Gross Margin (2021-2026)
- 7.1.4 Schott AG Injectable Packaging Product Portfolio
- 7.1.5 Schott AG Recent Developments
- 7.2 Gerresheimer AG
- 7.2.1 Gerresheimer AG Company Information
- 7.2.2 Gerresheimer AG Business Overview
- 7.2.3 Gerresheimer AG Injectable Packaging Revenue and Gross Margin (2021-2026)
- 7.2.4 Gerresheimer AG Injectable Packaging Product Portfolio
- 7.2.5 Gerresheimer AG Recent Developments
- 7.3 West Pharmaceutical Services
- 7.3.1 West Pharmaceutical Services Company Information
- 7.3.2 West Pharmaceutical Services Business Overview
- 7.3.3 West Pharmaceutical Services Injectable Packaging Revenue and Gross Margin (2021-2026)
- 7.3.4 West Pharmaceutical Services Injectable Packaging Product Portfolio
- 7.3.5 West Pharmaceutical Services Recent Developments
- 7.4 Stevanato Group
- 7.4.1 Stevanato Group Company Information
- 7.4.2 Stevanato Group Business Overview
- 7.4.3 Stevanato Group Injectable Packaging Revenue and Gross Margin (2021-2026)
- 7.4.4 Stevanato Group Injectable Packaging Product Portfolio
- 7.4.5 Stevanato Group Recent Developments
- 7.5 Becton, Dickinson and Company
- 7.5.1 Becton, Dickinson and Company Company Information
- 7.5.2 Becton, Dickinson and Company Business Overview
- 7.5.3 Becton, Dickinson and Company Injectable Packaging Revenue and Gross Margin (2021-2026)
- 7.5.4 Becton, Dickinson and Company Injectable Packaging Product Portfolio
- 7.5.5 Becton, Dickinson and Company Recent Developments
- 7.6 Catalent
- 7.6.1 Catalent Company Information
- 7.6.2 Catalent Business Overview
- 7.6.3 Catalent Injectable Packaging Revenue and Gross Margin (2021-2026)
- 7.6.4 Catalent Injectable Packaging Product Portfolio
- 7.6.5 Catalent Recent Developments
- 7.7 SGD Pharma
- 7.7.1 SGD Pharma Company Information
- 7.7.2 SGD Pharma Business Overview
- 7.7.3 SGD Pharma Injectable Packaging Revenue and Gross Margin (2021-2026)
- 7.7.4 SGD Pharma Injectable Packaging Product Portfolio
- 7.7.5 SGD Pharma Recent Developments
- 7.8 Nipro Corporation
- 7.8.1 Nipro Corporation Company Information
- 7.8.2 Nipro Corporation Business Overview
- 7.8.3 Nipro Corporation Injectable Packaging Revenue and Gross Margin (2021-2026)
- 7.8.4 Nipro Corporation Injectable Packaging Product Portfolio
- 7.8.5 Nipro Corporation Recent Developments
- 7.9 Datwyler Group
- 7.9.1 Datwyler Group Company Information
- 7.9.2 Datwyler Group Business Overview
- 7.9.3 Datwyler Group Injectable Packaging Revenue and Gross Margin (2021-2026)
- 7.9.4 Datwyler Group Injectable Packaging Product Portfolio
- 7.9.5 Datwyler Group Recent Developments
- 7.10 Stevanato Group's Ompi
- 7.10.1 Stevanato Group's Ompi Company Information
- 7.10.2 Stevanato Group's Ompi Business Overview
- 7.10.3 Stevanato Group's Ompi Injectable Packaging Revenue and Gross Margin (2021-2026)
- 7.10.4 Stevanato Group's Ompi Injectable Packaging Product Portfolio
- 7.10.5 Stevanato Group's Ompi Recent Developments
- 7.11 SGD Pharma's Gerresheimer
- 7.11.1 SGD Pharma's Gerresheimer Company Information
- 7.11.2 SGD Pharma's Gerresheimer Business Overview
- 7.11.3 SGD Pharma's Gerresheimer Injectable Packaging Revenue and Gross Margin (2021-2026)
- 7.11.4 SGD Pharma's Gerresheimer Injectable Packaging Product Portfolio
- 7.11.5 SGD Pharma's Gerresheimer Recent Developments
8 North America
- 8.1 North America Injectable Packaging Revenue (2021-2032)
- 8.2 North America Injectable Packaging Revenue by Type (2021-2032)
- 8.2.1 North America Injectable Packaging Revenue by Type (2021-2026)
- 8.2.2 North America Injectable Packaging Revenue by Type (2027-2032)
- 8.3 North America Injectable Packaging Revenue Share by Type (2021-2032)
- 8.4 North America Injectable Packaging Revenue by Application (2021-2032)
- 8.4.1 North America Injectable Packaging Revenue by Application (2021-2026)
- 8.4.2 North America Injectable Packaging Revenue by Application (2027-2032)
- 8.5 North America Injectable Packaging Revenue Share by Application (2021-2032)
- 8.6 North America Injectable Packaging Revenue by Country
- 8.6.1 North America Injectable Packaging Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Injectable Packaging Revenue by Country (2021-2026)
- 8.6.3 North America Injectable Packaging Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Injectable Packaging Revenue (2021-2032)
- 9.2 Europe Injectable Packaging Revenue by Type (2021-2032)
- 9.2.1 Europe Injectable Packaging Revenue by Type (2021-2026)
- 9.2.2 Europe Injectable Packaging Revenue by Type (2027-2032)
- 9.3 Europe Injectable Packaging Revenue Share by Type (2021-2032)
- 9.4 Europe Injectable Packaging Revenue by Application (2021-2032)
- 9.4.1 Europe Injectable Packaging Revenue by Application (2021-2026)
- 9.4.2 Europe Injectable Packaging Revenue by Application (2027-2032)
- 9.5 Europe Injectable Packaging Revenue Share by Application (2021-2032)
- 9.6 Europe Injectable Packaging Revenue by Country
- 9.6.1 Europe Injectable Packaging Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Injectable Packaging Revenue by Country (2021-2026)
- 9.6.3 Europe Injectable Packaging Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Injectable Packaging Revenue (2021-2032)
- 10.2 China Injectable Packaging Revenue by Type (2021-2032)
- 10.2.1 China Injectable Packaging Revenue by Type (2021-2026)
- 10.2.2 China Injectable Packaging Revenue by Type (2027-2032)
- 10.3 China Injectable Packaging Revenue Share by Type (2021-2032)
- 10.4 China Injectable Packaging Revenue by Application (2021-2032)
- 10.4.1 China Injectable Packaging Revenue by Application (2021-2026)
- 10.4.2 China Injectable Packaging Revenue by Application (2027-2032)
- 10.5 China Injectable Packaging Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Injectable Packaging Revenue (2021-2032)
- 11.2 Asia Injectable Packaging Revenue by Type (2021-2032)
- 11.2.1 Asia Injectable Packaging Revenue by Type (2021-2026)
- 11.2.2 Asia Injectable Packaging Revenue by Type (2027-2032)
- 11.3 Asia Injectable Packaging Revenue Share by Type (2021-2032)
- 11.4 Asia Injectable Packaging Revenue by Application (2021-2032)
- 11.4.1 Asia Injectable Packaging Revenue by Application (2021-2026)
- 11.4.2 Asia Injectable Packaging Revenue by Application (2027-2032)
- 11.5 Asia Injectable Packaging Revenue Share by Application (2021-2032)
- 11.6 Asia Injectable Packaging Revenue by Country
- 11.6.1 Asia Injectable Packaging Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Injectable Packaging Revenue by Country (2021-2026)
- 11.6.3 Asia Injectable Packaging Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Injectable Packaging Revenue (2021-2032)
- 12.2 SAMEA Injectable Packaging Revenue by Type (2021-2032)
- 12.2.1 SAMEA Injectable Packaging Revenue by Type (2021-2026)
- 12.2.2 SAMEA Injectable Packaging Revenue by Type (2027-2032)
- 12.3 SAMEA Injectable Packaging Revenue Share by Type (2021-2032)
- 12.4 SAMEA Injectable Packaging Revenue by Application (2021-2032)
- 12.4.1 SAMEA Injectable Packaging Revenue by Application (2021-2026)
- 12.4.2 SAMEA Injectable Packaging Revenue by Application (2027-2032)
- 12.5 SAMEA Injectable Packaging Revenue Share by Application (2021-2032)
- 12.6 SAMEA Injectable Packaging Revenue by Country
- 12.6.1 SAMEA Injectable Packaging Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Injectable Packaging Revenue by Country (2021-2026)
- 12.6.3 SAMEA Injectable Packaging Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst